Difficulties in describing allergic disease modulation by pre-, pro- and synbiotics

Current Pharmaceutical Design

Volumn 18, Issue 16, 2012, Pages 2369-2374

  Jeurink, Prescilla V ^a,b   Rijnierse, Anneke ^a,b   Martin, Rocio ^a   Garssen, Johan ^a,b   Knippels, Léon M J ^a,b  

^a DANONE RESEARCH   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Allergic diseases; Prebiotics; Probiotics; Synbiotics

Indexed keywords

FRUCTOSE OLIGOSACCHARIDE; GALACTOSE OLIGOSACCHARIDE; IMMUNOGLOBULIN E; INULIN; OLIGOSACCHARIDE; PREBIOTIC AGENT; PROBIOTIC AGENT; SYNBIOTIC AGENT;

ALLERGIC DISEASE; BIFIDOBACTERIUM; CLINICAL ASSESSMENT; DIETARY FIBER; DRUG EFFICACY; DRUG STRUCTURE; HUMAN; HYGIENE HYPOTHESIS; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOMODULATION; INTESTINE FLORA; LACTOBACILLUS; NONHUMAN; NUTRITIONAL STATUS; PRIORITY JOURNAL; REVIEW; TH1 CELL; TH2 CELL;

HUMANS; HYPERSENSITIVITY; PROBIOTICS;

EID: 84860213475     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161212800166031     Document Type: Review

References (53)

1. Walker WA, Weng MQ. Bacterial colonization, probiotics, and clinical disease. J Pediatr 2006; 149(5): S107-S14.
2. Roberfroid M, Gibson GR, Hoyles L, et al. Prebiotic effects: metabolic and health benefits. Br J Nutr 2010; 104: S1-S63.
3. He F, Ouwehand AC, Isolauri E, et al. Comparison of mucosal adhesion and species identification of bifidobacteria isolated fi-om healthy and allergic infants. Fems Immunol Med Microbiol 2001; 30(1): 43-47.
4. Penders J, Thijs C, van den Brandt PA, et al. Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut 2007; 56(5): 661-667.
5. Tang MLK, Lahtinen SJ, Boyle RJ. Probiotics and prebiotics: clinical effects in allergic disease. Curr Opin Pediatr 2010; 22(5): 626-634.
6. Vebo HC, Sekelja M, Nestestog R, et al. Temporal development of the infant gut microbiota in IgE sensitized and non-sensitized children determined by the GA-map infant array. Clin Vaccine Immunol 2011; 18(8): 1326-1335.
7. Schwab C, Ganzle M. Lactic acid bacteria fermentation of human milk oligosaccharide components, human milk oligosaccharides and galactooligosaccharides. FEMS Microbiol Lett 2010; 315(2): 141-148.
8. Sjogren YM, Duchen K, Lindh F, Bjorksten B, Sverremark-Ekstrom E. Neutral oligosaccharides in colostrum in relation to maternal allergy and allergy development in children up to 18 months of age. Pediatr Allergy Immunol 2007; 18(1): 20-26.
9. FAO/WHO. Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria: Joint FAO/WHO Expert Consultation 2001.
10. Boesten RJ, de Vos WM. Interactomics in the human intestine: Lactobacilli and Bifidobacteria make a difference. J Clin Gastroenterol 2008; 42 (Suppl 3) Pt 2: S163-S167.
11. Gourbeyre P, Denery S, Bodinier M. Probiotics, prebiotics, and synbiotics: impact on the gut immune system and allergic reactions. J Leukoc Biol 2011; 89(5): 685-95.
12. Boehm G, Stahl B. In: In: T, M-S (Ed) Functional Dairy Products, Oligosaccharides. Cambridge 2003; pp. 203-243.
13. Cummings JH, Stephen AM. Carbohydrate terminology and classification. Eur J Clin Nutr 2007; 61 (Suppl 1): S5-S18.
14. Rijnierse A, Jeurink PV, Garssen J, Knippels LMJ. Food-derived oligosaccharides exhibit pharmaceutical properties. European Journal of Pharmacology 2011(Special Issue: Pharma-Nutrition).
15. de Kivit S, Kraneveld AD, Garssen J, Willemsen LE. Glycan recognition at the interface of the intestinal immune system: Target for immune modulation via dietary components. Eur J Pharmacol 2011; 668 (Suppl 1): S124-S132.
16. Cardelle-Cobas A, Corzo N, Olano A, et al. Galactooligosaccharides derived from lactose and lactulose: Influence of structure on Lactobacillus, Streptococcus and Bifidobacterium growth. Int J Food Microbiol 2011; 149(1): 81-87.
17. Kekkonen RA, Holma R, Hatakka K, et al. A probiotic mixture including galactooligosaccharides decreases fecal beta-glucosidase activity but does not affect serum enterolactone concentration in men during a two-week intervention. J Nutr 2011; 141(5): 870-876.
18. Manning TS, Gibson GR. Microbial-gut interactions in health and disease. Prebiotics. Best Pract Res Clin Gastroenterol 2004; 18(2): 287-298.
19. Gruber C, van Stuijvenberg M, Mosca F, et al. Reduced occurrence of early atopic dermatitis because of immunoactive prebiotics among low-atopy-risk infants. J Allergy Clin Immunol 2010; 126(4): 791-797.
20. Amano J, Osanai M, Orita T, Sugahara D, Osumi K. Structural determination by negative-ion MALDI-QIT-TOFMSn after pyrene derivatization of variously fucosylated oligosaccharides with branched decaose cores from human milk. Glycobiology 2009; 19(6): 601-614.
21. Jeurink PV, van Hylckama-Vlieg J, Lesic-Arsic B, et al. In: Nijkamp FP, Parnham MJ, Eds. Principles of Immunopharmacology, Immunopharmacology of probiotics and prebiotics, Berlin: Springer 2010.
22. Hunt KM, Foster JA, Forney LJ, et al. Characterization of the diversity and temporal stability of bacterial communities in human milk. PLoS One 2011; 6(6): e21313.
23. Martin R, Langa S, Reviriego C, et al. Human milk is a source of lactic acid bacteria for the infant gut. J Pediatr 2003; 143(6): 754-758.
24. Gopal PK, Sullivan PA, Smart JB. Utilisation of galactooligosaccharides as selective substrates for growth by lactic acid bacteria including Bifidobacterium lactis DR10 and Lactobacillus rhamnosus DR20. International Dairy Journal 2001; 11(1-2): 19-25.
25. Schouten B, van Esch BC, Hofman GA, et al. Cow milk allergy symptoms are reduced in mice fed dietary synbiotics during oral sensitization with whey. J Nutr 2009; 139(7): 1398-1403.
26. Arumugam M, Raes J, Pelletier E, et al. Enterotypes of the human gut microbiome. Nature 2011; 473(7346): 174-180.
27. Land Bvt, Boehm G, Garssen J. Breast milk: components with immune modulating potential and their possible role in immune mediated disease resistance. In: Watson RR, Zibadi S, Preedy VR, Eds. Dietary Components and Immune Function. Berlin: Humana Press 2010; pp. 25-41.
28. Gell PGH, Coombs RRA. In: Clinical Aspects of Immunology. Oxford, England 1963
29. Spergel JM. From atopic dermatitis to asthma: the atopic march. Ann Allergy Asthma Immunol 2010; 105(2): 99-106; quiz 7-9, 17.
30. Rhodes HL, Sporik R, Thomas P, Holgate ST, Cogswell JJ. Early life risk factors for adult asthma: A birth cohort study of subjects at risk. Journal of Allergy and Clinical Immunology 2001; 108(5): 720-725.
31. Spergel JM, Mizoguchi E, Brewer JP, et al. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J Clin Invest 1998; 101(8): 1614-1622.
32. Vos AP, Haarman M, Buco A, et al. A specific prebiotic oligosaccharide mixture stimulates delayed-type hypersensitivity in a murine influenza vaccination model. Int Immunopharmacol 2006; 6(8): 1277-1286.
33. Boyle RJ, Bath-Hextall FJ, Leonardi-Bee J, Murrell DF, Tang MLK. Probiotics for treating eczema. Cochrane Database Syst Rev 2008; (4): CD006135.
34. Rodriguez-Cabezas ME, Camuesco D, Arribas B, et al. The combination of fructooligosaccharides and resistant starch shows prebiotic additive effects in rats. Clin Nutr 2010; 29(6): 832-839.
35. Rijkers GT, Bengmark S, Enck P, et al. Guidance for substantiating the evidence for beneficial effects of probiotics: current status and recommendations for future research. J Nutr 2011; 140(3): 671S-676S.
36. Hougee S, Vriesema AJ, Wijering SC, et al. Oral treatment with probiotics reduces allergic symptoms in ovalbumin-sensitized mice: a bacterial strain comparative study. Int Arch Allergy Immunol 2010; 151(2): 107-117.
37. Brouwer ML, Wolt-Plompen SA, Dubois AE, et al. No effects of probiotics on atopic dermatitis in infancy: a randomized placebocontrolled trial. Clin Exp Allergy 2006; 36(7): 899-906.
38. Folster-Holst R, Muller F, Schnopp N, et al. Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate to severe atopic dermatitis. Br J Dermatol 2006; 155(6): 1256-1261.
39. Gruber C, Wendt M, Sulser C, et al. Randomized, placebocontrolled trial of Lactobacillus rhamnosus GG as treatment of atopic dermatitis in infancy. Allergy 2007; 62(11): 1270-1276.
40. Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema. Clin Exp Allergy 2000; 30(11): 1604-1610.
41. Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 1997; 99(2): 179-185.
42. Viljanen M, Savilahti E, Haahtela T, et al. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a doubleblind placebo-controlled trial. Allergy 2005; 60(4): 494-500.
43. Kalliomaki M, Antoine JM, Herz U, et al. Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of allergic diseases by probiotics. J Nutr 2011; 140(3): 713S-721S.
44. Johansson SG, Bieber T, Dahl R, et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004; 113(5): 832-836.
45. van der Aa LB, Heymans HS, van Aalderen WM, Sprikkelman AB. Probiotics and prebiotics in atopic dermatitis: review of the theoretical background and clinical evidence. Pediatr Allergy Immunol 2010; 21(2 Pt 2): e355-e367.
46. van der Aa LB, Heymans HS, van Aalderen WM, et al. Effect of a new synbiotic mixture on atopic dermatitis in infants: a randomized-controlled trial. Clin Exp Allergy 2010; 40(5): 795-804.
47. van der Aa LB, van Aalderen WM, Heymans HS, et al. Synbiotics prevent asthma-like symptoms in infants with atopic dermatitis. Allergy 2011; 66(2): 170-177.
48. Flinterman AE, Knol EF, van Ieperen-van Dijk AG, et al. Probiotics have a different immunomodulatory potential in vitro versus ex vivo upon oral administration in children with food allergy. Int Arch Allergy Immunol 2007; 143(3): 237-244.
49. Osborn DA, Sinn JK. Prebiotics in infants for prevention of allergic disease and food hypersensitivity. Cochrane Database of Systematic Reviews 2007(4).
50. Su P, Henriksson A, Mitchell H. Prebiotics enhance survival and prolong the retention period of specific probiotic inocula in an in vivo murine model. J Appl Microbiol 2007; 103(6): 2392-2400.
51. Piirainen L, Kekkonen RA, Kajander K, et al. In school-aged children a combination of galacto-oligosaccharides and Lactobacillus GG increases bifidobacteria more than Lactobacillus GG on its own. Ann Nutr Metab 2008; 52(3): 204-208.
52. Grimoud J, Durand H, Courtin C, et al. In vitro screening of probiotic lactic acid bacteria and prebiotic glucooligosaccharides to select effective synbiotics. Anaerobe 2010; 16(5): 493-500.
53. Schouten B. Cow's milk allergy - Immune modulation by dietary intervention. Utrecht: Utrecht University 2009.